Skip to main content
Premium Trial:

Request an Annual Quote

Talis Biomedical: Jeryl Hilleman

Point-of-care infectious disease firm Talis Biomedical has appointed Jeryl Hilleman to its board of directors, where she will serve as the chair of the audit committee. Currently, she serves as chairman of the board of Omada Health and is a director of Novocure, SI-Bone, and Minerva Neurosciences. Previously, Hilleman was CFO at multiple publicly traded companies, including Intersect ENT, Ocera Therapeutics, Amyris, Symyx Technologies, and Cytel.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.